Australian Health Practitioner Regulation Agency - Ahpra

23/02/2026

Ahpra is reviewing endometriosis and pelvic pain concerns.

Read more: https://bit.ly/4s9jS4k

18/02/2026

Wishing you a blessed Ramadan.

16/02/2026

The Chinese Medicine Board of Australia wishes you strength, energy, and good fortune as we enter the Year of the Fire Horse 2026.

Listen to Board Chair, Professor Danforn Lim's message below.

16/02/2026

🤔 Did you know that if you have a concern about a practitioner's health, performance or conduct in QLD or NSW, you should contact a different regulator?

➡️ In NSW it's either the Health Professional Councils Authority or the Health Care Complaints Commission

➡️ And in QLD it's the Office of the Health Ombudsman.

For all other states and territories, report your concern to Ahpra.

Learn more: https://bit.ly/4bYbrUz

09/02/2026

✅ Do you want to use your experience to support the Medical Board and Nursing or Midwifery Boards of Australia?

✅ Are you passionate about public safety?

If so, we want to hear from you.

View current vacancies here: https://bit.ly/2UsDTZi

05/02/2026

The best care happens when health practitioners work together.

Aboriginal and Torres Strait Islander Health Practitioners, nurses and midwives at Danila Dilba Health Service and Royal Darwin Hospital talk about how partnering as equals helps ensure their care is culturally safe.

If you want to know what good partnerships look like, and how to build them into your everyday practice, check out the NMBA’s Guidance for nurses and midwives working with Aboriginal and Torres Strait Islander Health Practitioners: https://bit.ly/4tejhjf

03/02/2026

We have issued infringement notices to Prime Medic Group Pty Ltd (Prime Medic) and an individual for the alleged unlawful advertising of weight loss medicines in contravention of the Therapeutic Goods Act 1989 (the Act).

One infringement notice for $19,800 was issued to Prime Medic, and one for $3,960 was issued to the individual. Prime Medic and the individual paid the infringement notices in January 2026.

Prime Medic operates an online telehealth platform offering consultations with doctors. It is alleged that Prime Medic advertised prescription-only weight loss medicines, Ozempic and Mounjaro, directly to consumers between at least January and July 2025.

Advertising prescription-only medicines directly to consumers is prohibited under the Act, as it can create inappropriate demand and undermine the relationship between patients and their treating health practitioner. Decisions about appropriate treatment options should be made by a patient, in consultation with their health professional.

It is also alleged that the advertising promoted the use of therapeutic goods for the treatment of serious diseases, conditions or disorders. Such references are known as restricted or prohibited representations and are not allowed to be included in advertising for therapeutic goods unless approval or permission is given by the TGA.

Health providers must understand their legal obligations before advertising therapeutic goods.

Read more: https://www.tga.gov.au/news/media-releases/prime-medic-group-issued-infringement-notices-alleged-unlawful-advertising-weight-loss-medicines

29/01/2026

We have issued 11 infringement notices totalling $43,560, to 6 individuals, for the alleged unlawful importation of unapproved therapeutic goods and the alleged unlawful advertising of therapeutic goods, in contravention of the Therapeutic Goods Act 1989 (the Act).

Therapeutic goods that are not entered in the Australian Register of Therapeutic Goods (ARTG), also referred to as unapproved therapeutic goods, have not been assessed by the TGA for quality, safety and efficacy and may pose a health risk.

The Personal Importation Scheme permits individuals to import certain therapeutic goods not included in the ARTG, provided all legislative conditions are met. In these cases, the individuals did not obtain the required approvals or authorities.

The importation of counterfeit products is unlawful under any circumstance.

All 6 individuals, including 3 Australian Health Practitioner Regulation Agency (Ahpra) registered health practitioners, are alleged to have imported unapproved therapeutic goods in breach of the Act.

One Victorian-based health practitioner is also alleged to have imported counterfeit cosmetic injectables, which pose serious safety risks due to unknown composition or contamination.

In addition, a NSW-based individual is alleged to have unlawfully advertised botulinum toxin (botox) products on a social media platform.

In Australia, botulinum toxin type A is classified as a prescription-only medicine. Advertising prescription-only medicines directly to consumers is prohibited under the Act, as it can create inappropriate demand and undermine the relationship between patients and their treating health practitioner. The decision to use prescription-only medicines should be made between a prescribing health practitioner and their patient based on informed consent, including a discussion of possible side effects.

“These actions send a clear message that importing unapproved therapeutic goods or unlawfully advertising prescription-only medicines is unacceptable," said Professor Anthony Lawler, Deputy Secretary of the Department of Health, Disability and Ageing and Head of the TGA. “The TGA will continue to take strong compliance action and work closely with our regulatory and law-enforcement partners to protect Australians from unsafe or misleading products."

Read more: https://www.tga.gov.au/news/media-releases/tga-issues-infringement-notices-6-individuals-alleged-importation-and-unlawful-advertising-therapeutic-goods

25/01/2026

Today, on 26 January, we acknowledge that this date holds different meanings for many Australians and invites reflection on our shared history.

We recognise and respect Aboriginal and Torres Strait Islander peoples as the First Nations of this land and acknowledge the ongoing impact of colonisation.

As a profession committed to health, inclusion, and respect, the APA remains committed to listening, learning, and supporting culturally safe healthcare for all Australians.

We encourage everyone to use this day to reaffirm their commitment to reconciliation, reflect and embrace the value of truth-telling as we learn from our collective history.

22/01/2026

✅ Do you want to use your experience to support the Chinese Medicine Board of Australia?

✅ Are you passionate about public safety?

If so, we want to hear from you.

Read more about the vacancies and apply before 8 Feb: https://bit.ly/3ZbI1uJ

21/01/2026

21/01/2026

The Nursing and Midwifery Board of Australia is consulting on the revised standards for practice for Enrolled nurses and Registered nurses.

These standards have been reviewed to ensure they stay up to date, are grounded in evidence and are consistent with international regulatory practice.

Have your say by Friday 13 March: https://bit.ly/2o6AoEj